Goldman Sachs’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.3K Buy
40,454
+2,833
+8% +$3.04K ﹤0.01% 6418
2026
Q1
$38K Sell
37,621
-3,764
-9% -$5.14K ﹤0.01% 6318
2025
Q4
$47.2K Sell
41,385
-6,408
-13% -$6.6K ﹤0.01% 6294
2025
Q3
$54.5K Buy
+47,793
New +$58.8K ﹤0.01% 6168
2017
Q3
Sell
-61,416
Closed -$607K 6752
2017
Q2
$607K Buy
+61,416
New +$605K ﹤0.01% 4928
2016
Q3
Sell
-51,040
Closed -$755K 7094
2016
Q2
$755K Buy
+51,040
New +$636K ﹤0.01% 4451

Other funds holding IRIX

Goldman Sachs's IRIX Position: Q2 2026 in Review

Goldman Sachs increased its IRIDEX (IRIX) stake by 7.5% in Q2 2026, buying an estimated $3.04K and bringing the position to 40,454 shares worth $46.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6418.

Goldman Sachs first reported a position in IRIX in Q2 2016 and has held it in 6 quarters since. The position peaked at $755K in Q2 2016. 29 funds tracked by Wall St. Rank hold IRIX as of Q2 2026.

  • Goldman Sachs held 40,454 shares of IRIDEX worth $46.3K as of Q2 2026.
  • Goldman Sachs bought 2,833 IRIDEX shares in Q2 2026, an estimated $3.04K.
  • IRIDEX made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6418 holding.
  • Goldman Sachs first reported a position in IRIDEX in Q2 2016 and has held it in 6 quarters since.
  • Goldman Sachs's IRIDEX position peaked at $755K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held IRIDEX as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.